R. Lai

Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody

L. Lannfelt, H. Basun, A. Satlin, 2016, Alzheimer's Research & Therapy.

The ELISA system for measuring antibody reactive to Fusobacterium nucleatum in the sera of patients with chronic periodontitis.

C. Spiegel, W. Falkler, J. Vincent, 1982, Journal of periodontology.

Phase 1 Single Ascending and Multiple Ascending Dose Studies of Phosphodiesterase-9 Inhibitor E2027

E. Schuck, P. Boyd, J. Aluri, 2022, Alzheimer disease and associated disorders.

E2027 Cardiac Safety Evaluation With Concentration-Response Modeling of ECG Data to Inform Dose Selection in Studies in Patients With Dementia With Lewy Bodies

B. Darpo, J. Aluri, Hongqi Xue, 2022, Alzheimer disease and associated disorders.

A multimodal imaging study of mAb158, a murine monoclonal antibody with high selectivity for amyloid protofibrils, in Tg2576 mice

L. Lannfelt, B. Navia, A. Satlin, 2013, Alzheimer's & Dementia.

Lecanemab, an anti-Aβ protofibril antibody: Updated data from a randomized, double-blind phase 2B proof of concept clinical trial and open-label extension in early Alzheimer's disease

M. Hodgkinson, J. Kaplow, C. Swanson, 2021, Journal of the Neurological Sciences.